Novartis Shakes Suit Over Bone Drug Warnings

Law360, New York (November 1, 2011, 1:18 PM EDT) -- Novartis Pharmaceuticals Corp. on Monday won summary judgment in a Georgia suit remanded from multidistrict litigation claiming the company failed to warn that its bone drugs Aredia and Zometa were linked to bone death in the jaw.

Novartis has so far scored victories in two trials stemming from state or federal consolidated products liability litigation over Aredia and Zometa. The company is hoping for a retrial in a third case in which a jury initially told Novartis to pay $12.8 million to the plaintiff, but a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Eberhart v. Novartis Pharmaceuticals Corporation


Case Number

1:08-cv-02542

Court

Georgia Northern

Nature of Suit

Personal Inj. Prod. Liability

Judge

William S. Duffey, Jr

Date Filed

August 7, 2008

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.